Enhanced Genomics\u2019 decision to extend its Series A funding round has resulted in a total Series A funding raise of $19million.<\/p>\n
The biotechnology company is pioneering 3D multi-omics to rapidly identify high-confidence, genetically validated drug targets for common diseases.<\/p>\n
CEO Hazel Jones with Enhanced Genomics team in The Jeffreys Building, St John\u2019s Innovation Centre. Picture: Keith Heppell<\/p>\n
By translating massive amounts of disease-associated data into actionable insights, Enhanced identifies high-confidence targets with strong genetic evidence of causality, increasing the probability of success in drug development in a fraction of the time and cost previously possible.<\/p>\n
The funding will be used to expand Enhanced\u2019s internal therapeutic pipeline in common diseases, including autoimmune conditions such as inflammatory bowel disease.<\/p>\n
\u201cOur founders have led the field by developing technology to map 3D interactions on a whole-genome scale, and integrating these data with comprehensive multi-omics datasets,\u201d said Dietrich Stephan, chair, Enhanced Genomics.<\/p>\n
Dietrich Stephan, chair, Enhanced Genomics<\/p>\n
\u201cWe now have the technological capabilities to decipher the causal biology that drives complex and common genetic diseases, with the potential to develop truly effective new blockbuster therapies.<\/p>\n
\u201cThis puts us in a strong position to lead the next major shift in pharma. When developing a novel approach to drug discovery, clarity of thought and courage are required to build deep conviction, and we are proud to have built a team that embodies this. We thank our investors for continuing to support our vision.\u201d<\/p>\n","protected":false},"excerpt":{"rendered":"Enhanced Genomics\u2019 decision to extend its Series A funding round has resulted in a total Series A funding…\n","protected":false},"author":2,"featured_media":145221,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[25],"tags":[84,916,90,56,54,55],"class_list":["post-145220","post","type-post","status-publish","format-standard","has-post-thumbnail","category-genetics","tag-business","tag-genetics","tag-science","tag-uk","tag-united-kingdom","tag-unitedkingdom"],"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/uk\/wp-json\/wp\/v2\/posts\/145220","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/uk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/uk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/uk\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/uk\/wp-json\/wp\/v2\/comments?post=145220"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/uk\/wp-json\/wp\/v2\/posts\/145220\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/uk\/wp-json\/wp\/v2\/media\/145221"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/uk\/wp-json\/wp\/v2\/media?parent=145220"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/uk\/wp-json\/wp\/v2\/categories?post=145220"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/uk\/wp-json\/wp\/v2\/tags?post=145220"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}